Lumexa Imaging Holdings, Inc. Common Stock

LMRINASDAQHealthcare● Active

$8.25

$-0.26(-3.00%)

Market Cap$792185660

P/E Ratio—

52W High$19.45

52W Low$6.45

Avg Volume1.0M

Open$8.59

Beta2.18

Overview

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

LMRI · earnings · updated Jun 8, 2026

Latest Earnings

Q2 FY2026Report Date: May 12, 2026

EPS Actual

$0.18

Est. $0.12 · +50.0%

Revenue

$0.25B

Est. $0.25B · +1.2%

Fiscal Period

Q2 FY2026

FY ends December

Report Date

May 12, 2026

After Market Close

▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak

LMRI reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Rev. $0.58B

Days Away85

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

Rev. Est.$0.58B

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Aug 11, 2026	$0.16	—	—	—	$0.26B	—
◌ Q2 FY2026	Jun 3, 2026	$0.12	—	—	—	$0.25B	—
▲ Q2 FY2026	May 12, 2026	$0.12	$0.18	+50.0%	$0.25B	$0.25B	+1.2%
▼ Q1 FY2026	Mar 26, 2026	$0.05	-$0.66	-1420.0%	$0.27B	$0.26B	+2.5%
— Q4 FY2025	Dec 3, 2025	—	-$0.03	—	$0.26B	—	—

Q3 FY2026

Aug 11, 2026

EPS Actual

—

EPS Est.

$0.16

EPS Surpr.

—

Revenue

—

Q2 FY2026

Jun 3, 2026

EPS Actual

—

EPS Est.

$0.12

EPS Surpr.

—

Revenue

—

Q2 FY2026

May 12, 2026Beat

EPS Actual

$0.18

EPS Est.

$0.12

EPS Surpr.

+50.0%

Revenue

$0.25B

Q1 FY2026

Mar 26, 2026Miss

EPS Actual

-$0.66

EPS Est.

$0.05

EPS Surpr.

-1420.0%

Revenue

$0.27B

Q4 FY2025

Dec 3, 2025

EPS Actual

-$0.03

EPS Est.

—

EPS Surpr.

—

Revenue

$0.26B

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2028	$0.27	$0.27	$0.27	1
Q3 FY2028	$0.25	$0.25	$0.25	1
Q2 FY2028	$0.24	$0.24	$0.24	1
Q1 FY2028	$0.22	$0.22	$0.22	1
Q4 FY2027	$0.24	$0.24	$0.25	1
Q3 FY2027	$0.21	$0.21	$0.22	1

Revenue Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2028	$0.3B	$0.3B	$0.3B	1
Q3 FY2028	$0.3B	$0.3B	$0.3B	1
Q2 FY2028	$0.3B	$0.3B	$0.3B	1
Q1 FY2028	$0.3B	$0.3B	$0.3B	1
Q4 FY2027	$0.3B	$0.3B	$0.3B	2
Q3 FY2027	$0.3B	$0.3B	$0.3B	2

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▲ Q2 FY2026	May 12, 2026	+50.0%	$10.16	$10.50	+3.35%
▼ Q1 FY2026	Mar 26, 2026	-1420.0%	$11.06	$7.76	-29.84%
— Q4 FY2025	Dec 3, 2025	—	No price data	$18.52	—

Q2 FY2026+3.35%

Report Date

May 12, 2026

EPS Beat/Miss

+50.0%

Price Before

$10.16

Price After

$10.50

Q1 FY2026-29.84%

Report Date

Mar 26, 2026

EPS Beat/Miss

-1420.0%

Price Before

$11.06

Price After

$7.76

Q4 FY2025—

Report Date

Dec 3, 2025

EPS Beat/Miss

—

Price Before

—

Price After

$18.52

Avg Beat Reaction+3.35%

Avg Miss Reaction-29.84%

Beat Rate1 / 3 quarters

Largest Move-29.84% (Q1 FY2026)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $0.18 — beating the analyst consensus of $0.12 by +50.0%. The next LMRI earnings date is expected around September 1, 2026.

Each quarter, investors track LMRI earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. LMRI revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

LMRI's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

LMRI earnings · 5 questions

Lumexa Imaging Holdings, Inc. Common Stock's next earnings report is expected around September 1, 2026. LMRI typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; LMRI historically reports after market close (AMC).

LMRI earnings datewhen is LMRI earningsLMRI next earnings datewhen does LMRI report earningsLMRI earnings calendar

▸ Source: FMP · Lumexa Imaging Holdings, Inc. Common Stock SEC filings · US GAAP · Lumexa Imaging Holdings, Inc. Common Stock SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026